Cite
The impacts of dipeptidyl- peptidase 4 (DPP-4) inhibitors on common female malignancies: A systematic review.
MLA
Niazmand, Anoosha, et al. “The Impacts of Dipeptidyl- Peptidase 4 (DPP-4) Inhibitors on Common Female Malignancies: A Systematic Review.” Gene, vol. 927, Nov. 2024, p. 148659. EBSCOhost, https://doi.org/10.1016/j.gene.2024.148659.
APA
Niazmand, A., Nedaeinia, R., Vatandoost, N., Jafarpour, S., Safabakhsh, S., Kolahdouz, M., Ferns, G. A., & Salehi, R. (2024). The impacts of dipeptidyl- peptidase 4 (DPP-4) inhibitors on common female malignancies: A systematic review. Gene, 927, 148659. https://doi.org/10.1016/j.gene.2024.148659
Chicago
Niazmand, Anoosha, Reza Nedaeinia, Nasimeh Vatandoost, Sima Jafarpour, Saeid Safabakhsh, Mahsa Kolahdouz, Gordon A Ferns, and Rasoul Salehi. 2024. “The Impacts of Dipeptidyl- Peptidase 4 (DPP-4) Inhibitors on Common Female Malignancies: A Systematic Review.” Gene 927 (November): 148659. doi:10.1016/j.gene.2024.148659.